Gene · 100302178
MIR1295A: microRNA 1295a
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MIR1295A: microRNA 1295a. Genes, record 100302178. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100302178
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants217
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR1295A papers | Newest fiscal year |
|---|---|---|---|
| P30AG072975 | Rush Alzheimer's Disease Research Center | 2 | 2025 |
| P30CA093373 | Cancer Center Support Grant P30 | 2 | 2025 |
| P30DK056350 | Nutrition Obesity Research Center (NORC) | 2 | 2025 |
| R35GM119787 | Neutrophil migration and inflammation | 2 | 2025 |
| U01AG072177 | KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology | 2 | 2025 |
| U19AG074879 | Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations | 2 | 2025 |
| IK4BX005219 | BLR&D Research Career Development Transition Award Application | 1 | 2025 |
| IK6BX004477 | BLR&D Research Career Scientist Award Application | 1 | 2025 |
| P01HL116263 | HDL Function in Human Disease | 1 | 2025 |
| P20GM103408 | Idaho INBRE Program | 1 | 2025 |
1 to 10 of 217Source NIH's project files
See all 217 nih grantsPapers1,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of Retraction: Long non-coding RNA ZFY-AS1 represses periodontitis tissue inflammation and oxidative damage via modulating microRNA-129-5p/DEAD-Box helicase 3 X-linked axis. | Bioengineered | 2026 | 42821372 | PubTator, text mining | PubMed |
| Computational screening of oncogenic genetic variations in tumor suppressor proteins driving gastric cancer pathogenesis. | PLoS One | 2026 | 42752674 | PubTator, text mining | PubMed |
| LncRNASNHG12 regulates the development of diabetic nephropathy through miR-129-5p/IL6ST axis. | Mol Biol Rep | 2026 | 42579189 | PubTator, text mining | PubMed |
| Coordinated gene-catalytic therapy to attenuate intervertebral disc degeneration: A beehive-like nucleic acid nanozyme for microenvironment modulation. | J Control Release | 2026 | 42575212 | PubTator, text mining | PubMed |
| miR-129-5p Modulates the ZEB1/2 Signaling Axis to Suppress Palmitic Acid-Induced Epithelial-Mesenchymal Transition and Barrier Dysfunction in ARPE-19 Cells. | J Ocul Pharmacol Ther | 2026 | 42494341 | PubTator, text mining | PubMed |
| MiR-129-5p is associated with chronic obstructive pulmonary disease status and alleviates cigarette smoke extract-induced human bronchial epithelial cell injury. | Tob Induc Dis | 2026 | 42388843 | PubTator, text mining | PubMed |
| Sonobiopsy for enrichment of circulating microRNAs in glioma patients. | Neurooncol Adv | 2026 | 42311796 | PubTator, text mining | PubMed |
| RETRACTION: Depletion of lncRNA MEG3 Ameliorates Imatinib-Induced Injury of Cardiomyocytes via Regulating miR-129-5p/HMGB1 Axis. | Anal Cell Pathol (Amst) | 2026 | 42286935 | PubTator, text mining | PubMed |
| The Effect of miR-129-5p on the Proliferation and Osteogenic Differentiation of Human Dental Pulp Stem Cells. | Int Dent J | 2026 | 42242011 | PubTator, text mining | PubMed |
| Peripheral miRNA profiling identifies therapy-specific biological trajectories in the treatment of cognitive dysfunction in depression: an exploratory mechanistic study. | Sci Rep | 2026 | 42215657 | PubTator, text mining | PubMed |
1 to 10 of 1,306
See all 1,306 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/100302178
GET https://conductscience.org/api/genes/v1/100302178/grants?page=2